Stephanie E. Siegmund

Stephanie E. Siegmund

Auto-generated profile, based on publicly available information

Stephanie E. Siegmund

Department of Pathology Brigham and Women's Hospital Boston Massachusetts USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2017 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
SSStephanie E Siegmund
Stephanie E Siegmund
HYHua Yang
Hua Yang
RSRohit Sharma
Rohit Sharma
MJMartin Javors
Martin Javors
OSOwen Skinner
Owen Skinner
ESEric A Schon
Eric A Schon
Mitochondrial disorders affecting oxidative phosphorylation (OxPhos) are caused by mutations in both the nuclear and mitochondrial genomes. One promising candidate for treatment is the drug rapamycin, which has been shown to extend lifespan in multiple animal models, and which was previously shown to ameliorate mitochondrial disease in a knock-out mouse model lacking a nuclear-encoded gene specifying an OxPhos structural subunit (Ndufs4). In that model, relatively high-dose intraperitoneal rapamycin extended lifespan and improved markers of neurological disease, via an unknown mechanism. Here, we administered low-dose oral rapamycin to a knock-in (KI) mouse model of authentic mtDNA disease, specifically, progressive mtDNA depletion syndrome, resulting from a mutation in the mitochondrial nucleotide salvage enzyme thymidine kinase 2 (TK2). Importantly, low-dose oral rapamycin was sufficient to extend Tk2KI/KI mouse lifespan significantly, and did so in the absence of detectable improvements in mitochondrial dysfunction. We found no evidence that rapamycin increased survival by acting through canonical pathways, including mitochondrial autophagy. However, transcriptomics and metabolomics analyses uncovered systemic metabolic changes pointing to a potential ‘rapamycin metabolic signature.’ These changes also implied that rapamycin may have enabled the Tk2KI/KI mice to utilize alternative energy reserves, and possibly triggered indirect signaling events that modified mortality through developmental reprogramming. From a therapeutic standpoint, our results support the possibility that low-dose rapamycin, while not targeting the underlying mtDNA defect, could represent a crucial therapy for the treatment of mtDNA-driven, and some nuclear DNA-driven, mitochondrial diseases.

1 August 2018 in iScience
Verified
Journal Article
Open access
SSStephanie E. Siegmund
Stephanie E. Siegmund
RGRobert Grassucci
Robert Grassucci
SCStephen D. Carter
Stephen D. Carter
EBEmanuele Barca
Emanuele Barca
ZFZachary J. Farino
Zachary J. Farino
ZFZachary Z. Freyberg
Zachary Z. Freyberg
Mitochondrial diseases produce profound neurological dysfunction via mutations affecting mitochondrial energy production, including the relatively common Leigh syndrome (LS). We recently described an LS case caused by a pathogenic mutation in USMG5, encoding a small supernumerary subunit of mitochondrial ATP synthase. This protein is integral for ATP synthase dimerization, and patient fibroblasts revealed an almost total loss of ATP synthase dimers. Here, we utilize in situ cryoelectron tomography (cryo-ET) in a clinical case-control study of mitochondrial disease to directly study mitochondria within cultured fibroblasts from a patient with LS and a healthy human control subject. Through tomographic analysis of patient and control mitochondria, we find that loss of ATP synthase dimerization due to the pathogenic mutation causes profound disturbances of mitochondrial crista ultrastructure. Overall, this work supports the crucial role of ATP synthase in regulating crista architecture in the context of human disease.

3 April 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
SCStephen D. Carter
Stephen D. Carter
CHCheri M. Hampton
Cheri M. Hampton
RLRobert Langlois
Robert Langlois
RMRoberto Melero
Roberto Melero
ZFZachary J. Farino
Zachary J. Farino
ZFZachary Z. Freyberg
Zachary Z. Freyberg
Ribosome-associated vesicles are a novel, dynamic ER-derived organelle.

16 July 2012 in The Plant Journal
Verified
Journal Article
Open access
PDF file
MBManuela D. Bienert
Manuela D. Bienert
SSStephanie E. G. Siegmund
Stephanie E. G. Siegmund
ADAnna Drozak
Anna Drozak
Tomasz TrombikTomasz Trombik
Tomasz Trombik
ABAlain Bultreys
Alain Bultreys
MBMarc Boutry
Marc Boutry
Summary: Pleiotropic drug resistance (PDR) transporters are a group of membrane proteins belonging to the ABCG sub‐family of ATP binding cassette (ABC) transporters. There is clear evidence for the involvement of plant ABC transporters in resistance to fungal and bacterial pathogens, but not in the biotic stress response to insect or herbivore attack. Here, we describe a PDR transporter, ABCG5/PDR5, from Nicotiana tabacum. GFP fusion and subcellular fractionation studies revealed that ABCG5/PDR5 is localized to the plasma membrane. Staining of transgenic plants expressing the GUS reporter gene under the control of the ABCG5/PDR5 transcription promoter and immunoblotting of wild‐type plants showed that, under standard growth conditions, ABCG5/PDR5 is highly expressed in roots, stems and flowers, but is only expressed at marginal levels in leaves. Interestingly, ABCG5/PDR5 expression is induced in leaves by methyl jasmonate, wounding, pathogen infiltration, or herbivory by Manduca sexta. To address the physiological role of ABCG5/PDR5, N. tabacum plants silenced for the expression of ABCG5/PDR5 were obtained. No phenotypic modification was observed under standard conditions. However, a small increase in susceptibility to the fungus Fusarium oxysporum was observed. A stronger effect was observed in relation to herbivory: silenced plants allowed better growth and faster development of M. sexta larvae than wild‐type plants, indicating an involvement of this PDR transporter in resistance to M. sexta herbivory.

26 April 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
PLPin-Chao Liao
Pin-Chao Liao
IBIstvan R Boldogh
Istvan R Boldogh
SSStephanie E Siegmund
Stephanie E Siegmund
ZFZachary Z. Freyberg
Zachary Z. Freyberg
LPLiza A. Pon
Liza A. Pon
Isolated mitochondria are widely used to study the function of the organelle. Typically, mitochondria are prepared using differential centrifugation alone or in conjunction with density gradient ultracentrifugation. However, mitochondria isolated using differential centrifugation contain membrane or organelle contaminants, and further purification of crude mitochondria by density gradient ultracentrifugation requires large amounts of starting material, and is time-consuming. Mitochondria have also been isolated by irreversible binding to antibody-coated magnetic beads. We developed a method to prepare mitochondria from budding yeast that overcomes many of the limitations of other methods. Mitochondria are tagged by insertion of 6 histidines (6xHis) into the TOM70 (Translocase of outer membrane 70) gene at its chromosomal locus, isolated using Ni-NTA (nickel (II) nitrilotriacetic acid) paramagnetic beads and released from the magnetic beads by washing with imidazole. Mitochondria prepared using this method contain fewer contaminants, and are similar in ultrastructure as well as protein import and cytochrome c oxidase complex activity compared to mitochondria isolated by differential centrifugation. Moreover, this isolation method is amenable to small samples, faster than purification by differential and density gradient centrifugation, and more cost-effective than purification using antibody-coated magnetic beads. Importantly, this method can be applied to any cell type where the genetic modification can be introduced by CRISPR or other methods.

29 March 2019 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
RLRan Li
Ran Li
XZXiangrui Zeng
Xiangrui Zeng
SSStephanie E. Sigmund
Stephanie E. Sigmund
RLRuogu Lin
Ruogu Lin
BZBo Zhou
Bo Zhou
MXMin Xu
Min Xu
Cryo-electron tomography (cryo-ET) enables the 3D visualization of cellular organization in near-native state which plays important roles in the field of structural cell biology. However, due to the low signal-to-noise ratio (SNR), large volume and high content complexity within cells, it remains difficult and time-consuming to localize and identify different components in cellular cryo-ET. To automatically localize and recognize in situ cellular structures of interest captured by cryo-ET, we proposed a simple yet effective automatic image analysis approach based on Faster-RCNN. Our experimental results were validated using in situ cyro-ET-imaged mitochondria data. Our experimental results show that our algorithm can accurately localize and identify important cellular structures on both the 2D tilt images and the reconstructed 2D slices of cryo-ET. When ran on the mitochondria cryo-ET dataset, our algorithm achieved Average Precision >0.95. Moreover, our study demonstrated that our customized pre-processing steps can further improve the robustness of our model performance. In this paper, we proposed an automatic Cryo-ET image analysis algorithm for localization and identification of different structure of interest in cells, which is the first Faster-RCNN based method for localizing an cellular organelle in Cryo-ET images and demonstrated the high accuracy and robustness of detection and classification tasks of intracellular mitochondria. Furthermore, our approach can be easily applied to detection tasks of other cellular structures as well.